Financhill
Sell
21

KALV Quote, Financials, Valuation and Earnings

Last price:
$10.77
Seasonality move :
6.97%
Day range:
$10.41 - $10.89
52-week range:
$7.30 - $17.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
382.88x
P/B ratio:
13.35x
Volume:
803.1K
Avg. volume:
1.1M
1-year change:
-3.58%
Market cap:
$544.6M
Revenue:
--
EPS (TTM):
-$4.00

Earnings Data

Next earnings date for KALV
Nov 11
2025
Most recent earnings per share
-$1.12
Missed by $0.17
(Sep 11/2025)
Consensus Estimate
-$0.96
(Sep 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KALV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/31/2026 Q1 $12.1M -- -- -$0.94 --
11/11/2025 Q4 $7.5M -- -- -$1.07 --
09/11/2025 Q3 $2.1M $1.4M -$1.12 -$0.96 -$0.17
07/07/2025 Q2 $3.2M -- -$1.05 -$0.81 -$0.24
03/13/2025 Q1 -- -- -$0.92 -$0.87 -$0.05
12/05/2024 Q4 -- -- -$0.91 -$0.91 $0.00
09/05/2024 Q3 -- -- -$0.87 -$0.95 $0.07
07/11/2024 Q2 -- -- -$1.02 -$0.72 -$0.30
03/11/2024 Q1 -- -- -$0.84 -$0.80 -$0.04
12/07/2023 Q4 -- -- -$0.80 -$0.78 -$0.02
09/07/2023 Q3 -- -- -$0.74 -$0.84 $0.10
04/30/2023 Q2 -- -- -$0.77 -- --
03/09/2023 Q1 -- -- -$0.75 -- --
12/08/2022 Q4 -- -- -$0.90 -- --
09/08/2022 Q3 -- -- -$0.94 -- --
04/30/2022 Q2 -- -- -$0.98 -- --
03/10/2022 Q1 -- -- -$0.92 -- --
12/09/2021 Q4 -- -- -$0.80 -- --
09/09/2021 Q3 -- -- -$0.66 -- --
07/13/2021 Q2 -- -- -$0.65 -- --
03/11/2021 Q1 -- -- -$0.56 -- --
12/10/2020 Q4 -- -- -$0.58 -- --
09/14/2020 Q3 -- -- -$0.61 -- --
07/01/2020 Q2 -- $3.8M -$0.37 -- --
03/10/2020 Q1 -- $1.6M -$0.52 -- --
12/03/2019 Q4 -- $3.9M -$0.33 -- --
09/09/2019 Q3 -- $3.4M -$0.42 -- --
07/15/2019 Q2 -- $2.9M -$0.49 -- --
03/15/2019 Q1 -- $3.9M -$0.23 -- --
12/14/2018 Q4 -- $5.6M -$0.22 -- --
07/31/2018 Q3 -- $3.7M -$0.47 -- --
04/30/2018 Q2 -- $4.8M -$0.06 -- --
03/16/2018 Q1 -- $2.3M -$0.49 -- --
12/14/2017 Q4 -- $1.1M -$0.50 -- --
10/10/2017 Q3 -- $96K -$0.51 -- --
04/30/2017 Q2 -- $114K -$0.43 -- --
01/31/2017 Q1 -- $248K -$1.03 -- --
12/31/2015 Q4 -- $8K -$3.01 -- --

KalVista Pharmaceuticals, Inc. Earnings Questions

  • How Much did KalVista Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    KalVista Pharmaceuticals, Inc. reported $1.4M worth of top line sales in its most recent quarter.

  • Did KalVista Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    KalVista Pharmaceuticals, Inc. announced earnings per share of -$1.12 which represents a miss of analyst forecast a -$0.96 per share.

  • Is KalVista Pharmaceuticals, Inc. Profitable?

    KalVista Pharmaceuticals, Inc. reported $584K that represents $0.01 per share over the last quarter.

  • What is the Analyst Consensus for KalVista Pharmaceuticals, Inc. EPS Next Year?

    KalVista Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.69 per share to -$3.74 per share next year representing a decrease of -2.48%.

  • When is KalVista Pharmaceuticals, Inc.'s Earnings Date?

    KalVista Pharmaceuticals, Inc.'s next earnings date is November 11, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is PayPal Stock Finally a Buy?
Is PayPal Stock Finally a Buy?

Shares of online payment giant PayPal (NASDAQ:PYPL) have struggled over…

Why Did Sprouts Stock Fall So Much?
Why Did Sprouts Stock Fall So Much?

Shares of health-oriented grocery chain Sprouts Farmers Market (NASDAQ:SFM) have…

Why Did Amazon Go Up So Much?
Why Did Amazon Go Up So Much?

Shares of Amazon (NASDAQ:AMZN) soared late last week, bringing the…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 36x

Alerts

Buy
100
GMED alert for Nov 8

Globus Medical, Inc. [GMED] is up 35.94% over the past day.

Buy
73
GCT alert for Nov 8

GigaCloud Technology, Inc. [GCT] is up 30.05% over the past day.

Buy
84
FROG alert for Nov 8

JFrog Ltd. [FROG] is up 26.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock